Green Dream with Regnan’s Crockford: The industry is taking a breather
Investors are beginning to really understand the different flavours of sustainability, says the Regnan impact manager
Healthcare
-
-
Antitrust and ESG
The progressive weakening of antitrust since the early 1980s raises important governance concerns about market influence
-
ESG changed my mind on…what brings about meaningful change
Columbia Threadneedle’s Harry Waight discusses investing in healthcare and why he’s cycling around London
-
World Population Day: ‘Investment in global systems must be strengthened’
Ongoing population expansion and urbanisation create a number of challenges
-
Health needs to be part of the conversation about investments in nature
GSK’s VP of sustainability writes exclusively for ESG Clarity on the health benefits of investing in nature
-
CIRCA5000 launches impact-focused ETF range
Focusing on five key areas
-
UK mid-cap ESG opportunities following FTSE 250’s worst year
Compelling company choice with many mid-cap names leading the way on responsible and sustainable business models
-
Menopause support for women lacking in financial services
Some feel this is caused by ageism and gender discrimination
-
Sustainable Standpoint: ESG was never more misunderstood than in the past year
In the first part of this new series, ESG industry experts reflect on 2022 and share predictions for 2023
-
Four sectors for ESG income investors
Pockets of opportunity exist for investors willing to cast their net wider
-
Why anti-microbial resistance is an ESG risk investors need to be thinking about
Tackling this ‘silent pandemic’ requires a global coordinated policy
-
Investment giants collaborate to improve health outcomes
Long-term Investors in People’s Health programme backed by L&G, Rathbone Greenbank and Federated Hermes